The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
The Contract Research Organization and the Commercialization of Scientific Research
Abstract
The early 1980s constituted a watershed in science, mainly concerning the extent and nature of globalization and commercialization of scientific research, and its impact upon the university. Considerable debate has arisen about the sources of this transition, but aside from a few lone voices, the scholarly literature has neglected the concurrent rise of the contract research organization (CRO) and its role in the commercialization of scientific research. The CRO warrants wider attention as a modern paradigm of privatized science in the biopharmaceutical sector. In discussing the CRO’s technologies, the purposes they pursue, and the legal and policy initiatives that have fostered their rapid rise, we confront the wider implications of the modern regime of commercialized science for the future conduct of scientific research. We identify five areas of innovation: treatment of human subjects, control of disclosure, subjection of research tools to commercialization, redefinition of authorship, and re-engineering the goals of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can Patents Deter Innovation? The Anticommons in Biomedical Research
Heller, M. A., & Eisenberg, R. S. (1998) · Science · doi:10.1126/science.280.5364.698 · Cited by 2,572
Toward a new economics of science
Partha, D., & David, P. A. (1994) · Research Policy · doi:10.1016/0048-7333(94)01002-1 · Cited by 2,448
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“One recent examination of published surveys and meta-analyses of drug efficacy found that ‘[s]tudies sponsored by pharmaceutical companies were more likely to have outcomes favoring the sponsor than were studies with other sponsors’ (Lexchin et al., 2003: 1167).”
ResultScope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Bernstein, H. L., Horowitz, D. L., Lange, D. L., Powell, H. J., Shimm, M. G., Weistart, J. C., Danner, R. A., Germain, C., Baccari, B. A., Eichhorn, L. A., et al. (1990) · Cited by 1,803
Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?
Wazana, A. (2000) · JAMA · doi:10.1001/jama.283.3.373 · Cited by 1,415
Universities in the marketplace: the commercialization of higher education
(2003) · Choice Reviews Online · doi:10.5860/choice.41-1047 · Cited by 1,321
Vanderbilt Journal of Transnational Law
Finch, E. H. (1972) · American Journal of International Law · doi:10.1017/s0002930000206908 · Cited by 1,190
Information Feudalism: Who Owns the Knowledge Economy?
Ingram, M. C., Drahos, P., & Braithwaite, J. (2003) · Contemporary Sociology · doi:10.2307/1556517 · Cited by 826
Private Power, Public Law: The Globalization of Intellectual Property Rights
Sell, S. K. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511491665 · Cited by 768
Uneasy alliance—clinical investigators and the pharmaceutical industry
Bodenheimer, T. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422024 · Cited by 765
Conflict of Interest in the Debate over Calcium-Channel Antagonists
Stelfox, H. T., Chua, G., O'Rourke, K., & Detsky, A. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380206 · Cited by 615
Private power, public law the globalization of intellectual property rights
Sell, S. K. (2003) · Cited by 568
Prevalence of Articles With Honorary Authors and Ghost Authors in Peer-Reviewed Medical Journals
Flanagin, A. (1998) · JAMA · doi:10.1001/jama.280.3.222 · Cited by 553
MIT and the Rise of Entrepreneurial Science
Etzkowitz, H. (2002) · Routledge eBooks · doi:10.4324/9780203216675 · Cited by 540
Dickersin, K. (2003) · JAMA · doi:10.1001/jama.290.4.516 · Cited by 512
Heller, M., & Eisenberg, R. S. (1998) · Cited by 492
Data Withholding in Academic Genetics: Evidence From a National Survey
Campbell, E. G., Clarridge, B. R., Gokhale, M., Birenbaum, L., Hilgartner, S., Holtzman, N. A., & Blumenthal, D. (2002) · JAMA · doi:10.1001/jama.287.4.473 · Cited by 489
Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology
Friedberg, M. (1999) · JAMA · doi:10.1001/jama.282.15.1453 · Cited by 477
Participation of Life-Science Faculty in Research Relationships with Industry
Blumenthal, D., Campbell, E. G., Causino, N., & Louis, K. S. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352305 · Cited by 461
Kjaergard, L., & Als-Nielsen, B. (2002) · BMJ · doi:10.1136/bmj.325.7358.249 · Cited by 433
HICKS, D. (1995) · Industrial and Corporate Change · doi:10.1093/icc/4.2.401 · Cited by 408
Owen-Smith, J., & Powell, W. W. (2003) · Research Policy · doi:10.1016/s0048-7333(03)00045-3 · Cited by 407
Source of funding and outcome of clinical trials
Davidson, R. A. (1986) · Journal of General Internal Medicine · doi:10.1007/bf02602327 · Cited by 397
Patents in the Knowledge-Based Economy
(2003) · National Academies Press eBooks · doi:10.17226/10770 · Cited by 366
The Drugs Don't Work: Expectations and the Shaping of Pharmacogenetics
Hedgecoe, A., & Martin, P. (2003) · Social Studies of Science · doi:10.1177/03063127030333002 · Cited by 340
Scientific Authorship. Credit and Intellectual Property in Science
Pontille, D., Biagioli, M., & Galison, P. (2004) · Revue Française de Sociologie · doi:10.2307/3323164 · Cited by 280
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420020059007 · Cited by 277
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.2.157 · Cited by 274
Sponsorship, Authorship, and Accountability
Davidoff, F. (2001) · New England Journal of Medicine · doi:10.1056/nejmed20010093 · Cited by 270
The myth of the biotech revolution
Nightingale, P., & Martin, P. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.09.010 · Cited by 259
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.
(1894) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1894.02421170027003 · Cited by 257
The vexed question of authorship: views of researchers in a British medical faculty
Bhopal, R., Rankin, J., McColl, E., Thomas, L., Kaner, E., Stacy, R., Pearson, P., Vernon, B., & Rodgers, H. (1997) · BMJ · doi:10.1136/bmj.314.7086.1009 · Cited by 242
Sponsorship, Authorship, and Accountability
(2001) · New England Journal of Medicine · doi:10.1056/nejmed010093 · Cited by 241
Prevalence of Honorary and Ghost Authorship in Cochrane Reviews
Mowatt, G. (2002) · JAMA · doi:10.1001/jama.287.21.2769 · Cited by 227
Influences on the Quality of Published Drug Studies
Bero, L. A., & Rennie, D. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009582 · Cited by 226
Policies on Faculty Conflicts of Interest at US Universities
Cho, M. K. (2000) · JAMA · doi:10.1001/jama.284.17.2203 · Cited by 224
Press, E., & Washburn, J. (2017) · Academic Ethics · doi:10.4324/9781315263465-15 · Cited by 224
The Economics of Science and Technology
Audretsch, D. B., Bozeman, B., Combs, K. L., Feldman, M., Link, A. N., Siegel, D. S., Stephan, P., Tassey, G., & Wessner, C. (2002) · The Journal of Technology Transfer · doi:10.1023/a:1014382532639 · Cited by 218
Interface between authorship, industry and science in the domain of therapeutics
Healy, D., & Cattell, D. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.183.1.22 · Cited by 218
Schulman, K. A., Seils, D. M., Timbie, J. W., Sugarman, J., Dame, L. A., Weinfurt, K. P., Mark, D. B., & Califf, R. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa020349 · Cited by 177
Disclosure of Researcher Contributions: A Study of Original Research Articles in The Lancet
Yank, V., & Rennie, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-8-199904200-00013 · Cited by 170
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
Bekelman, J. E., & Gross, C. P. (2006) · Cited by 166
University Licensing and the Bayh-Dole Act
Thursby, J. G., & Thursby, M. (2003) · Science · doi:10.1126/science.1087473 · Cited by 165
Medical journals and pharmaceutical companies: uneasy bedfellows
Smith, R. W. (2003) · BMJ · doi:10.1136/bmj.326.7400.1202 · Cited by 154
The pharmaceutical industry as a political player
Abraham, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11477-2 · Cited by 148
Medical Innovation and Institutional Interdependence
Gelijns, A. C., & Thier, S. O. (2002) · JAMA · doi:10.1001/jama.287.1.72 · Cited by 139
Rennie, D., Flanagin, A., & Yank, V. (2000) · JAMA · doi:10.1001/jama.284.1.89 · Cited by 132
Mirowski, P. (2004) · Studies in History and Philosophy of Science Part A · doi:10.1016/j.shpsa.2003.11.002 · Cited by 130
Self-citationBiagioli, M., & Galison, P. L. (2014) · Routledge eBooks · doi:10.4324/9780203954270 · Cited by 129
The Industrialization Of Clinical Research
Rettig, R. A. (2000) · Health Affairs · doi:10.1377/hlthaff.19.2.129 · Cited by 122
Pharmacopolitics: drug regulation in the United States and Germany
(2004) · Choice Reviews Online · doi:10.5860/choice.42-0332 · Cited by 113
Stopping Medical Research to Save Money
Psaty, B. M., & Rennie, D. (2003) · JAMA · doi:10.1001/jama.289.16.2128 · Cited by 102
Status of Clinical Research in Academic Health Centers
Campbell, E. G., Weissman, J. S., Moy, E. M., et al. (2001) · JAMA · doi:10.1001/jama.286.7.800 · Cited by 99
The Effortless Economy of Science?
Mirowski, P. (2004) · Duke University Press eBooks · doi:10.1215/9780822385646 · Cited by 96
Self-citationPharmacopolitics: Drug Regulation in the United States and Germany
Whitehead, T. (2005) · Social History of Medicine · doi:10.1093/sochis/hki044 · Cited by 95
Privatizing the University--the New Tragedy of the Commons
Brown, J. R. (2000) · Science · doi:10.1126/science.290.5497.1701 · Cited by 91
Financial Conflict-of-Interest Policies in Clinical Research: Issues for Clinical Investigators
Boyd, E. A., Cho, M. K., & Bero, L. A. (2003) · Academic Medicine · doi:10.1097/00001888-200308000-00002 · Cited by 81
The Moral Economy of the Drug Company–Medical Scientist Collaboration in Interwar America
Rasmussen, N. (2004) · Social Studies of Science · doi:10.1177/0306312704042623 · Cited by 76
Horton, R. (2002) · JAMA · doi:10.1001/jama.287.21.2775 · Cited by 75
Private science: biotechnology and the rise of molecular sciences
(1998) · Choice Reviews Online · doi:10.5860/choice.36-2149 · Cited by 68
Patients’ health or company profits? The commercialisation of academic research
Olivieri, N. F. (2003) · Science and Engineering Ethics · doi:10.1007/s11948-003-0017-x · Cited by 65
Dehue, T. (1999) · History of the Human Sciences · doi:10.1177/09526959922120199 · Cited by 62
Sponsorship, Authorship, and Accountability
Davidoff, F., DeAngelis, C. D., Drazen, J. M., Hoey, J., Højgaard, L., Horton, R., Kotzin, S., Nylenna, M., Overbeke, A. J. P. M., Sox, H. C., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00016 · Cited by 58
Globalization of Clinical Research by the Pharmaceutical Industry
Shah, S. (2003) · International Journal of Health Services · doi:10.2190/5fgj-03aq-bkw2-glaa · Cited by 56
The Drug Industry and Clinical Research in Interwar America: Three Types of Physician Collaborator
Rasmussen, N. (2005) · Bulletin of the history of medicine · doi:10.1353/bhm.2005.0036 · Cited by 55
Measuring the Pace of New Drug Development in the User Fee ERA
Kaitin, K. I., & DiMasi, J. A. (2000) · Drug Information Journal · doi:10.1177/009286150003400303 · Cited by 50
Díaz, D. V. (2004) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 45
The New Drug Approvals of 1996, 1997, and 1998: Drug Development Trends in the User Fee Era
Kaitin, K. I., & Healy, E. M. (2000) · Drug Information Journal · doi:10.1177/009286150003400101 · Cited by 45
Stone, T. H. (2003) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2003.tb00065.x · Cited by 45
Research Tool Patenting and Licensing and Biomedical Innovation
Walsh, J. P., Arora, A., & Cohen, W. M. (2018) · KiltHub Repository · doi:10.1184/r1/6471878 · Cited by 42
Andrews, R. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07506.x · Cited by 42
Need a Reagent? Just Sign Here ...
Marshall, E. (1997) · Science · doi:10.1126/science.278.5336.212 · Cited by 38
Hype in Health Reporting: “Checkbook Science” Buys Distortion of Medical News
Zuckerman, D. M. (2003) · International Journal of Health Services · doi:10.2190/pmm9-dput-hn3y-lmjq · Cited by 31
Physicians and the Pharmaceutical Industry: A Dysfunctional Relationship
Fisher, M. A. (2003) · Perspectives in biology and medicine · doi:10.1353/pbm.2003.0019 · Cited by 20
Getz, K. A., & de Bruin, A. (2000) · Drug Information Journal · doi:10.1177/009286150003400308 · Cited by 18
Re-engineering scientific credit in the era of the globalized information economy
Mirowski, P. (2001) · First Monday · doi:10.5210/fm.v6i12.903 · Cited by 17
Self-citationDuBois, W. C. (2003) · Vanderbilt journal of transnational law · Cited by 7
Research works printed but not linked: 83
- 10.1057/9780230372597 · doi:10.1057/9780230372597
- Agres, Ted, 2003, The Scientist, 17, 58
- Angell, Marcia, 2002, Daedalus, 102
- Azoulay, Pierre, 2002, ‘Acquiring Knowledge Within and Across Firm Boundaries’
- 10.3386/w10142 · DOI
- 10.1126/science.1087592 · doi:10.1126/science.1087592
- Berenson, Alex, 2004, New York Times, A1
- Bogdanich, Walt, 2002, Bill Moyers Now
- Breitstein, Joanna, 2001, Pharmaceutical Executive
- Croissant, Jennifer, 2001, Degrees of Compromise: Industrial Interests and Academic Values
- Datta, P., 2003, Financial Times
- Davies, Helen, Institute of Medicine on 21 August
- Davies, Helen, DIA 2002 Annual Meeting
- DeYoung, Karen, 2000, Washington Post
- Drahos, Peter, 2002, Information Feudalism
- 10.1016/S1359-6446(01)02137-7 · doi:10.1016/s1359-6446(01)02137-7
- Dreyfuss, Rachel, 2001, Expanding the Boundaries of Intellectual Property, 10.1093/oso/9780198298571.001.0001 · doi:10.1093/oso/9780198298571.001.0001
- Eisenberg, Rebecca, 2001, Expanding the Boundaries of Intellectual Property, 223, 10.1093/oso/9780198298571.003.0009 · doi:10.1093/oso/9780198298571.003.0009
- Eisenberg, Rebecca, 2003, Law and Contemporary Problems, 56, 289
- Elliott, Carl, 2002, London Review of Books, 36
- 10.1126/science.284.5419.1445b · doi:10.1126/science.284.5419.1445b
- 10.1353/pbm.2003.0020 · doi:10.1353/pbm.2003.0020
- 10.1007/978-1-4615-0981-3 · DOI
- Flaherty, Mary P., 2000, Washington Post, A1
- Forster, David, 2002, Seton Hall Law Review, 32, 513
- 2002, FY 2003 President’s Budget for Department of Health and Human Services
- Gad, Shane C., 2003, The Selection and Use of Contract Research Organizations
- Giombetti, Ric, 2002, ‘Suicide Science - Paxil’s Friendly Ghostwriter?’
- Goliszek, Andrew, 2003, In the Name of Science
- Greenberg, Daniel, 2001, Science, Money and Politics
- 10.1007/s11948-003-0020-2 · doi:10.1007/s11948-003-0020-2
- Hope, Janet, 2003, ‘Intellectual Property and the Biotechnology Revolution’
- Hughes, Graham, 2002, European Pharmaceutical Contractor
- Hughes, Sue, 2002, Heartwire
- Johnson, Erica, 2003, CBC Marketplace
- Kahin, Brian, 2001, First Monday, 6
- Kessler, David, 2001, A Question of Intent
- Kevles, Daniel, 1994, Historical Studies in the Physical and Biological Sciences, 25, 111, 10.2307/27757736 · doi:10.2307/27757736
- Krimsky, Sheldon, 2003, Science in the Private Interest
- Kunin, Stephen, 2002, American University Law Journal, 51, 608
- 10.1016/S0041-1345(03)00203-3 · doi:10.1016/s0041-1345(03)00203-3
- Lemonick, Michael, 2000, Time, 46
- 10.1080/1042771042000187907 · doi:10.1080/1042771042000187907
- Lessig, Larry, 2001, The Future of Ideas
- Lester, David, 2003, American Pharmaceutical Outsourcing
- McSherry, Corynne, 2001, Who Owns Academic Work?
- Magnus, David, 2002, Who Owns Life?
- Marks, Harry, 1997, The Progress of Experiment
- Maurer, Stephen, NRC Symposium on Information in the Public Domain
- Meier, Barry, 2004, New York Times, A1
- Milne, C., 2004, American Pharmaceutical Outsourcing
- Mirowski, Philip, 2001, First Monday
- Mirowski, Philip, 2002, Science Bought and Sold
- 10.1002/1099-1050(200012)9:8<659::AID-HEC578>3.0.CO;2-0 · doi:10.1002/1099-1050(200012)9:8<659::aid-hec578>3.0.co;2-0
- 10.1023/A:1007875910066 · doi:10.1023/a:1007875910066
- 10.1215/9780822385202 · doi:10.1215/9780822385202
- Newman, Nathan, 2002, Nation
- Nowotny, Helga, 2001, Rethinking Science
- Okie, Susan, 2001, Washington Post, A11
- Parexel, 2003, Pharmaceutical R&D Statistical Sourcebook
- Pear, Robert, 2003, New York Times
- 10.1016/S0166-4972(01)00081-5 · doi:10.1016/s0166-4972(01)00081-5
- Pollack, Andrew, 2002, New York Times
- Pollack, Andrew, 2004, New York Times, 1
- Pomfret, John, 2000, Washington Post
- Posner, Richard A., 2002, Daedalus, 5
- Press, Eyal, 2000, Atlantic Monthly, 285, 39
- Public Citizen Health Research Group, 2001, ‘Rx R&D Myths: The Case Against the Drug Industry’s R&D “Scare Card”’
- 10.1023/A:1015760920428 · doi:10.1023/a:1015760920428
- Reimers, Niels, 1998, Oral History
- Roman, Joanne, 2002, Cornell Journal of Law and Public Policy, 11, 441
- 10.1093/hmg/10.20.2261 · doi:10.1093/hmg/10.20.2261
- Ryan, Michael, 1998, Knowledge Diplomacy
- 10.1097/00001888-200212001-00006 · doi:10.1097/00001888-200212001-00006
- Shapin, Steven, 2003, London Review of Books, 15
- Sharma, B.L., 2003, Associated Press Worldstream
- Siegel, Marc, 2002, Nation
- Stephens, Joseph, 2000, Washington Post
- Stone, T. Howard, 2003, Currents in Contemporary Ethics, 31, 149
- Streitz, Wendy D., 2003, ‘Material Transfer Agreements: A Win-Win for Academia and Industry’ (Power Point presentation)
- 10.1016/S0041-1345(03)00202-1 · doi:10.1016/s0041-1345(03)00202-1
- Wilson, Duff, 2001, Seattle Times
- Zuckerman, Diana, 2002, Extra!
Cited by
Conflict of Interest in Medical Research, Education, and Practice
(2009) · National Academies Press eBooks · doi:10.17226/12598 · Cited by 807
Medical Micro/Nanorobots in Precision Medicine
Soto, F., Wang, J., Ahmed, R., & Demirci, U. (2020) · Advanced Science · doi:10.1002/advs.202002203 · Cited by 442
Ghosts in the Machine: Publication Planning in the Medical Sciences
Sismondo, S. (2009) · Social Studies of Science · doi:10.1177/0306312708101047 · Cited by 297
Sismondo, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040286 · Cited by 259
Introduction: STS and Neoliberal Science
Lave, R., Mirowski, P., & Randalls, S. (2010) · Social Studies of Science · doi:10.1177/0306312710378549 · Cited by 256
Self-citation
Metadata
- Authors
- Mirowski, P., & Van Horn, R.
- Venue
- Social Studies of Science
- Publisher
- SAGE Publications
- Published
- 2005-08
- Volume
- 35
- Issue
- 4
- Pages
- 503-548
- ISSN
- 0036-8539 (ISSN-L)
- 0306-3127
- 1460-3659
- OpenAlex
- W2172194321
- Cited by
- 260
- References
- 78
- FWCI
- 34.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.